0.00Open0.10Pre Close0 Volume30 Open Interest5.00Strike Price0.00Turnover903.09%IV1600.00%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.4860Delta0.5770Gamma3.01Leverage Ratio-0.0057Theta0.0000Rho1.46Eff Leverage0.0003Vega
Renalytix Stock Discussion
Renalytix plc, a leading artificial intelligence-enabled in vitro diagnostics company, has announced an exciting new collaboration with the Steno Diabetes Center in Copenhagen. This partnership aims to advance precision medicine solutions for patients suffering from diabetes and chronic kidney disease ...
?????????????????????
No comment yet